|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
EBSCO_ocn743802455 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
110801s2011 nyu ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d CDX
|d YDXCP
|d E7B
|d OCLCQ
|d GWM
|d OCLCQ
|d OCLCA
|d OCLCF
|d NLGGC
|d OCLCQ
|d D6H
|d AGLDB
|d OCLCO
|d JBG
|d OCLCO
|d TOA
|d OCLCO
|d PIFAG
|d OCLCO
|d WY@
|d VTS
|d OCLCO
|d TOF
|d OCLCO
|d OCLCA
|d STF
|d OCLCO
|d M8D
|d OCLCO
|d OCLCA
|d OCLCO
|d OCLCQ
|d IOY
|d OCLCQ
|
020 |
|
|
|a 9781617050220
|q (electronic bk.)
|
020 |
|
|
|a 1617050229
|q (electronic bk.)
|
020 |
|
|
|z 9781933864822
|
020 |
|
|
|z 1933864826
|
029 |
1 |
|
|a AU@
|b 000048636392
|
029 |
1 |
|
|a AU@
|b 000051355957
|
029 |
1 |
|
|a DEBBG
|b BV043145512
|
029 |
1 |
|
|a DEBSZ
|b 421567228
|
029 |
1 |
|
|a DKDLA
|b 830060-katalog:10488686
|
029 |
1 |
|
|a DKDLA
|b 860900-katalog:10488686
|
035 |
|
|
|a (OCoLC)743802455
|
050 |
|
4 |
|a RC647.C55
|b L37 2011eb
|
060 |
|
4 |
|a 2011 A-427
|
060 |
|
4 |
|a WH 322
|b L315c 2011
|
072 |
|
7 |
|a MED
|x 038000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.1/57075
|2 22
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Laposata, Michael.
|
245 |
1 |
0 |
|a Coagulation disorders :
|b quality in laboratory diagnosis /
|c Michael Laposata.
|
260 |
|
|
|a New York :
|b Demos Medical Pub.,
|c ©2011.
|
300 |
|
|
|a 1 online resource (xii, 145 pages).
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Diagnostic standards of care
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Monitoring of anticoagulant therapy and patients being treated with warfarin -- Monitoring of anticoagulant therapy in patients being treated with unfractionated heparin -- Monitoring of anticoagulant therapy in patients being treated with low molecular weight heparin -- Monitoring of anticoagulant therapy in patients being treated with fondaparinux -- Monitoring of anticoagulant therapy in patients being treated with lepirudin or argatroban -- Evaluation for heparin induced thrombocytopenia -- Evaluation of prolongations of the PT and the PTT, and assessment for deficiencies of coagulation factors -- Evaluation for disseminated intravascular coagulation -- Evaluation for a congenital hypercoagulable state -- Evaluation for antiphospholipid antibodies -- Evaluation for von Willebrand disease -- Evaluation for a coagulation factor VIII inhibitor -- Evaluation for thrombocytopenia that is not associated with heparin exposure -- Evaluation for platelet dysfunction in the presence or absence of antiplatelet agents.
|
588 |
0 |
|
|a Print version record.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Blood coagulation disorders
|x Diagnosis.
|
650 |
|
0 |
|a Diagnosis, Laboratory.
|
650 |
1 |
2 |
|a Blood Coagulation Disorders
|x diagnosis
|
650 |
2 |
2 |
|a Anticoagulants
|x therapeutic use
|
650 |
2 |
2 |
|a Blood Coagulation
|x physiology
|
650 |
2 |
2 |
|a Clinical Laboratory Techniques
|x methods
|
650 |
2 |
2 |
|a Medical Errors
|x prevention & control
|
650 |
|
6 |
|a Diagnostics biologiques.
|
650 |
|
7 |
|a MEDICAL
|x Hematology.
|2 bisacsh
|
650 |
|
7 |
|a Blood coagulation disorders
|x Diagnosis.
|2 fast
|0 (OCoLC)fst00834699
|
650 |
|
7 |
|a Diagnosis, Laboratory.
|2 fast
|0 (OCoLC)fst00892307
|
776 |
0 |
8 |
|i Print version:
|a Laposata, Michael.
|t Coagulation disorders.
|d New York : Demos Medical Pub., ©2011
|z 9781933864822
|w (DLC) 2010021811
|w (OCoLC)632070602
|
830 |
|
0 |
|a Diagnostic standards of care.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=379209
|z Texto completo
|
938 |
|
|
|a Coutts Information Services
|b COUT
|n 18402442
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10488686
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 379209
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 6980096
|
994 |
|
|
|a 92
|b IZTAP
|